Leptin modification in chronic myeloid leukemia patients treated with imatinib: An emerging effect of targeted therapy.()

We evaluated serum leptin levels in 9 young chronic myeloid leukemia (CML) patients under imatinib therapy during a long-term follow-up. Body mass index (BMI) and fat mass percentage (%FM) were also measured. Leptin was above the normal range in 8 out of 9 patients. In one case the hormone was below...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariani, Stefania, Basciani, Sabrina, Giona, Fiorina, Lubrano, Carla, Ulisse, Salvatore, Gnessi, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850368/
https://www.ncbi.nlm.nih.gov/pubmed/24371782
http://dx.doi.org/10.1016/j.lrr.2013.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850368/
https://www.ncbi.nlm.nih.gov/pubmed/24371782
http://dx.doi.org/10.1016/j.lrr.2013.07.001

Ejemplares similares